Virax Biolabs Group Limited

NasdaqCM:VRAX Stock Report

Market Cap: US$10.5m

Virax Biolabs Group Limited Company Information

Virax Biolabs Group Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Virax Biolabs Group Limited
  • Ticker: VRAX
  • Exchange: NasdaqCM
  • Founded: 2013
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Market Cap: US$10.464m
  • Shares Outstanding: 4.34m
  • Website: https://viraxbiolabs.com

Number of Employees


Location

  • Virax Biolabs Group Limited
  • BioCity Glasgow
  • Bo’Ness Road Newhouse
  • Lanarkshire
  • Lanarkshire
  • ML1 5UH
  • United Kingdom


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
VRAXNasdaqCM (Nasdaq Capital Market)YesOrdinary SharesUSUSDJul 2022

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/12 10:21
End of Day Share Price 2024/11/12 00:00
Earnings2024/03/31
Annual Earnings2024/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.